News

Today’s market action is dominated by a bunch of listings we’ve covered this week, plus a few fresh faces, like Cue Biopharma (NASDAQ:CUE), which is running strong after announcing, on Wednesday, that it will receive $7.5 million preclinical milestone payment for its agreement with Boehringer Ingelheim, while Xiao-I (NASDAQ:AIXI) has been in play since providing an update on its Apple (NASDAQ:AAPL) patent infringement lawsuit. $SKYQ, $KBLB, $UCAR, $ELAB, $CUE, $AIXI, $AAPL, $CREG, $RAYA

Lixte Biotechnology (NASDAQ: LIXT) is emerging as a differentiated player in the oncology ecosystem, advancing a precision-driven approach to cancer treatment which focuses on improving the effectiveness of existing. As a clinical-stage pharmaceutical company, the company is advancing novel compounds built around a unique biological target, with its lead candidate, LB-100, at the nucleus of its […]

ORLANDO, FL / ACCESS Newswire / April 10, 2026 / Unusual Machines, Inc. (NYSE American:UMAC), a leading manufacturer of NDAA-compliant drone components, today provided an update on its Orlando motor manufacturing operations, where recent changes are expected to more than double daily production. The Company is currently producing approximately 15,000 motors per month and has added second and third shifts. Updates to equipment, staffing, and factory layout are expected to increase daily production from approximately 700 to 1,500 parts per day as additional capacity comes online. Motor design and engineering are led by Vice President of Motors Andrew Simpson, who joined the Company through the acquisition of Rotor Lab and recently relocated to the United States. The Company has leveraged that foundational expertise to accelerate its transition to scaled manufacturing. Manufacturing operations are led by Vice President of Manufacturing Brad Mello, who led the establishment of the Orlando facility from the ground up and is driving current scaling efforts. "We're running motor production 24 hours a day, five days a week, and I'm proud of how the team has expanded and refined the operation in the five months since launch," said Andrew Camden, President and Chief Operating Officer. "We continue to push production higher by adding equipment and building out the team. Rotor Lab brought deep product experience, and we've paired that with our manufacturing capability to scale more quickly." The Company is expanding staffing across all three shifts, with motor factory personnel expected to roughly double in May as production ramps, and expects to install a high-volume automated motor production line in the second half of 2026 to further expand output. About Unusual Machines, Inc. Unusual Machines manufactures and sells drone components and drones across a diversified brand portfolio, which includes Fat Shark, the leader in FPV (first-person view) ultra-low latency video goggles for drone pilots. The Company also retails small, acrobatic FPV drones and equipment directly to consumers through the curated Rotor Riot ecommerce store. With a changing regulatory environment, Unusual Machines seeks to be a dominant Tier-1 parts supplier to the fast-growing multi-billion-dollar U.S. drone industry. According to Fact.MR, the global drone accessories market is currently valued at $17.5 billion and is set to top $115 billion by 2032. For more information, please visit unusualmachines.com. Safe Harbor Statement This press release contains forward-looking statements including the more than doubling of daily production, expanding of staffing in the motor factory, and the timing of the installation of automated production equipment. Forward-looking statements are often identifiable by the words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "objective," "ongoing," "plan," "predict," "project," "potential," "should," "will," or "would," or the negative of these terms, or other comparable terminology intended to identify statements about the future. These statements involve known and unknown risks, uncertainties, and other factors that may cause the Company's actual results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by these forward-looking statements. Although the Company believes that it has a reasonable basis for making each forward-looking statement contained in this press release, the Company cautions that these statements are based on a combination of facts and factors currently known by the Company and its expectations of the future, about which the Company cannot be certain. Forward-looking statements are subject to considerable risks and uncertainties, as well as other factors that may cause the Company's actual results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by these forward-looking statements. These risks and uncertainties include our reliance on third parties to deliver components needed to manufacture our motors and the various risk factors relating to manufacturing and other risks described within the section entitled "Risk Factors" in the Company's 2025 Annual Report on Form 10-K. The Company undertakes no obligation to update the information contained in this press release to reflect subsequently occurring events or circumstances, except as required by law. Investor Contact: investors@unusualmachines.com Media Contact: media@unusualmachines.com SOURCE: Unusual Machines, Inc. View the original press release on ACCESS Newswire

iSpecimen (NASDAQ:ISPC) is making a significant operational leap, announcing a revamped logistics model that dramatically reduces the time it takes to deliver human biospecimens to researchers worldwide.

Delivered 6,520 vehicles1 and achieved total revenue of $519 million in 2025. Service revenues increased 69% YoY in 2025, affirming the Company’s technology edge and validating the commercialization of its intellectual property (IP). Gross margin improved to 9% in 2025 mainly due to the commencement of upgraded model deliveries globally and disciplined cost control. Operating loss narrowed by 65% YoY and 29% QoQ in the fourth quarter, with the full-year operating loss narrowed by 46% YoY, demonstrating the Company’s commitment to operational efficiencies. Debut of Company’s first PHEV model, named For Me (Eletre X in Europe), extending product roadmap and catering to evolving consumer demands across diversified powertrain segments. NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- Lotus Technology Inc. (Nasdaq: LOT) (“Lotus Tech” or the “Company”), a leading global intelligent and luxury mobility provider, today announced its unaudited financial results for the fourth quarter and the year ended December 31, 2025. Operating Highlights of the Full Year of 2025 In 2025, the Company recorded total deliveries1 of 6,520 units, a transitional performance hampered by tariff headwinds, gradual inventory destocking and the phased rollout of upgraded models. Deliveries were predominantly driven by the China and Europe markets. China delivery growth outperformed the PRC premium automotive segment2, underscoring the competitiveness of the Company’s product portfolio amid an intensifying market landscape. Service revenues surged 69% YoY in 2025 to $56 million, primarily driven by R&D service revenue. The commercialization of the Company’s intellectual property through technical licensing and other avenues demonstrated significant market recognition of its pioneering technologies. Operating loss narrowed by 65% in the fourth quarter and 46% in the full year of 2025 on a YoY basis. The consecutive reductions in operating loss in the third and fourth quarters of 2025 were mainly driven by optimized product mix and stringent expense control, demonstrating the Company’s operational resilience amid intensified market competition. The Company has unveiled its first PHEV model, named For Me (also known as Eletre X in Europe), and commenced deliveries in China in March 2026, with a global release to follow, aimed at meeting worldwide customer demand for diversified powertrains. For Me is built on Lotus 900V X-Hybrid architecture, enabling a 0-100 km/h acceleration of 3.3 seconds and a combined cruising range of over 1,400 kilometers. Its comprehensive handling dynamics system delivers a 100-0 km/h braking distance of 33.9 meters, offering safety and confidence in emergency situations. Deliveries1 by Model Type  Full Year 2025Full Year 2024% Change (YoY)  Lifestyle SUV and Sedan4,5526,815(33%)  Sportscars1,9685,169(62%)  Total6,52011,984(46%)        Deliveries1 by Region  Full Year 2025Full Year 2024  UnitsRegion %UnitsRegion %  China2,96045%2,86824%  Europe2,19834%4,74340%  North America1,04816%2,57821%  Rest of the World3145%1,79515%  Total6,520100%11,984100%         Financial Highlights of the Full Year of 2025 Total revenues were $519 million, a 44% YoY decrease. Gross margin was 9%, versus 3% for the full year of 2024. Operating loss was $423 million, narrowed by 46% YoY. Net loss was $464 million, narrowed by 58% YoY. Adjusted EBITDA (non-GAAP) was a loss of $356 million, narrowed by 63% YoY. Key Financial Results The table below summarizes key preliminary financial results for the full year ended December 31, 2025. (in millions of U.S. dollars, unaudited)  Full Year 2025Full Year 2024% Change (YoY)  Revenue519924(44%)  Cost of revenue474895(47%)  Gross profit452953%  Gross margin (%)9%3%   Operating loss(423)(786)(46%)  Net loss(464)(1,107)(58%)  Adjusted net loss(A)(462)(1,075)(57%)  Adjusted EBITDA(A)(356)(961)(63%)        (A) Non-GAAP measure. See “Non-GAAP Financial Measures” and “Appendix D – Unaudited Reconciliation of GAAP and Non-GAAP results (Adjusted net loss/Adjusted EBITDA)” for details and a reconciliation of adjusted metrics to the nearest GAAP measure. Recent Developments Lotus Cup Racing Series: On November 30, 2025, the 2025 season of the inaugural Lotus Cup one-make racing series drew to a close at the Sepang International Circuit, with a total of 44 race-prepared Lotus Emira cars competing in the season finale. The Sepang International Circuit also hosted the season opener of the 2026 Lotus Cup one-make racing series, which officially commenced on April 3, 2026. New Strategic Investment: On December 23, 2025, the Company entered into a share subscription agreement with ECARX, pursuant to which ECARX agreed to subscribe for and purchase from the Company a total of 16,788,321 newly issued ordinary shares of the Company for a purchase price of US$23 million. This strategic investment is designed to significantly broaden the collaborative framework between the two companies, deepening the existing relationship into a more integrated, strategic global partnership. UN R171.01 Certification: On March 13, 2026, the Company announced that Eletre was certified under UN Regulation No. 171, 01 Series (UN R171.01) issued by the United Nations Economic Commission for Europe (UNECE), making it the first and only China-built model certified under this regulation and equipped with HNP function as of the press date, and making the Company the second globally operating automaker to achieve this certification. Milan Design Week: On April 1, 2026, the Company announced that Lotus will return to 2026 Milan Design Week with "IN PROGRESS", an exhibition created in collaboration with Haus of Automotive, showcasing Lotus D.N.A. design principles and Theory 1 concept, deepening luxury and craft collaborations to elevate its brand vision and global design influence. CEO and CFO Comments Mr. Qingfeng Feng, Chief Executive Officer, commented: "Despite the external headwinds facing our business, we maintained our Company’s mission and strategy by doubling down on cutting-edge technologies, refining our product mix, and providing an industry-leading driving performance. Our established global footprint is the impetus that allows us to seize first-mover gains and enables us to become the world’s second automaker to obtain UN R171.01 certification. Our differentiation and dedication to executing our growth and innovation strategy – represented by the launch of our first PHEV vehicle, which further enriches our powertrain offerings – together with our diversified product portfolio, provide us with the foundation to remain competitive in the market." Dr. Daxue Wang, Chief Financial Officer, commented: "Our improved margin performance in the fourth quarter and full year of 2025 demonstrated our continued focus on cost optimization and operational efficiency, and was also reflected in our significantly improved bottom line results. Going forward, we expect the global launch of “For Me” to supercharge sales and revenue. Additionally, we expect that by focusing on revenue growth efforts, maximizing our products and competitive positioning, and enhancing margin expansion through strict cost reductions, our business will progress toward profitability and we will deliver long-term value to our shareholders." Operating and Financial Results of the Fourth Quarter of 2025 Total revenues were $163 million, a 40% YoY decrease. Gross margin was 10%, versus -11% for the same period of 2024. Operating loss was $66 million, narrowed by 65% YoY. Net loss was $86 million, narrowed by 81% YoY. Adjusted EBITDA (non-GAAP) was a loss of $62 million, narrowed by 84% YoY. Deliveries1 by Model Type  4Q 20254Q 2024% Change (YoY)  Lifestyle SUV and Sedan1,2382,771(55%)  Sportscars6701,540(56%)  Total1,9084,311(56%)        Key Financial Results The table below summarizes key preliminary financial results for the fourth quarter in 2025. (in millions of U.S. dollars, unaudited)  4Q 20254Q 2024% Change (YoY)  Revenues163272(40%)  Cost of Revenues147301(51%)  Gross profit (loss)16(29)156%  Gross margin (%)10%(11%)   Operating loss(66)(189)(65%)  Net loss(86)(441)(81%)  Adjusted net loss(A)(86)(442)(81%)  Adjusted EBITDA(A)(62)(398)(84%)        (A)Non-GAAP measure. See “Non-GAAP Financial Measures” and “Appendix D – Unaudited Reconciliation of GAAP and Non-GAAP results (Adjusted net loss/Adjusted EBITDA)” for details and a reconciliation of adjusted metrics to the nearest GAAP measure. Conference Call Lotus Tech management will host an earnings conference call at 8:00 AM U.S. Eastern Time on Friday, April 10, 2026 (14:00 Central European Time / 20:00 China Standard Time on the same day). There will be a live audio webcast and limited-time replay available on the Company’s investor relations website at https://ir.group-lotus.com/news-events/events/. Participants who wish to view the live webcast may register at https://edge.media-server.com/mmc/p/g29k9vbj. Participants who wish to join the conference call, please complete online registration prior to the scheduled call start time using the link provided below. Upon registration, participants will receive a confirmation email with conference call access information, including dial-in numbers and a unique PIN. Participant online registration link: https://register-conf.media-server.com/register/BIe972002f75524fe8b4ea313e70dd459a. Note 1: Including commissioned deliveries in US market. The volume of delivery previously announced by the Company was based on the number of vehicles invoiced in the China market and the number of vehicles in relation to which revenue had been recognized for markets outside China, and included commissioned deliveries in the US market. Starting from the three months ended June 30, 2025, the presentation of delivery data has been unified and the volume of delivery reported represents the number of vehicles in relation to which revenue has been recognized for all markets and includes commissioned deliveries in the US market. Historical data presented in this press release has been adjusted to reflect this change. Note 2: Based on market data of retail sales volume in 2025 in Chinese mainland. Premium auto segment refers to passenger vehicles pricing over RMB 400,000. About Lotus Technology Inc. Lotus Technology Inc. has operations across the UK, the EU and China. The Company is dedicated to delivering luxury lifestyle electric vehicles, with a focus on world-class R&D in next-generation automobility technologies such as electrification, digitalisation and more. For more information about Lotus Technology Inc., please visit www.group-lotus.com. Non-GAAP Financial Measures The Company uses non-GAAP financial measures, including adjusted net loss and adjusted EBITDA in evaluating its operating results and for financial and operational decision-making purposes. Adjusted net loss represents net loss excluding share-based compensation expenses, and such adjustment has no impact on income tax. Lotus Tech defines adjusted EBITDA as net loss excluding interest income, interest expense, income tax expenses, depreciation of property, equipment and software, and share-based compensation expenses. The Company believes that non-GAAP financial measures help identify underlying trends in its business and enhance the overall understanding of the Company’s past performance and future prospects. The Company also believes that non-GAAP financial measures allow for greater visibility with respect to key metrics used by the Company’s management in its financial and operational decision-making. Non-GAAP financial measures are not presented in accordance with U.S. GAAP and may be different from non-GAAP methods of accounting and reporting used by other companies. Non-GAAP financial measures have limitations as analytical tools and when assessing the Company’s operating performance, investors should not consider them in isolation, or as a substitute for financial information prepared in accordance with U.S. GAAP. The Company encourages investors and others to review its financial information in its entirety and not rely on a single financial measure. The Company mitigates these limitations by reconciling non-GAAP financial measures to the most comparable U.S. GAAP performance measures, all of which should be considered when evaluating the Company’s performance. For more information on non-GAAP financial measures, please see "Appendix D – Unaudited Reconciliation of GAAP and Non-GAAP Results (Adjusted net loss/Adjusted EBITDA)" set forth at the end of this press release. Forward-Looking Statements This press release contains statements that may constitute “forward-looking” statements pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “expect”, “intend”, “will”, “estimate”, “anticipate”, “believe”, “predict”, “potential”, “forecast”, “plan”, “seek”, “future”, “propose” or “continue”, or the negatives of these terms or variations of them or similar terminology although not all forward-looking statements contain such terminology. Forward-looking statements involve inherent risks and uncertainties, including those identified under the heading “Risk Factors” in the Company’s filings with the U.S. Securities and Exchange Commission. All information provided in this press release is as of the date of this press release, and Lotus Tech undertakes no obligation to update any forward-looking statement, except as required under applicable law. Contact Information For investor inquiries ir@group-lotus.com Appendix A Lotus Technology Inc. Unaudited Condensed Consolidated Balance Sheets (All amounts in thousands)   As of    December 31, 2025  December 31, 2024    US$  US$  ASSETS       Current assets       Cash and cash equivalents 73,431  103,072  Restricted cash 375,865  379,293  Accounts receivable – third parties, net 36,850  117,076  Accounts receivable – related parties, net 114,126  107,816  Inventories 121,361  188,582  Prepayments and other current assets – third parties, net 77,570  72,541  Prepayments and other current assets – related parties, net 111,886  74,558          Total current assets 911,089  1,042,938          Non-current assets       Restricted cash 100,981  2,572  Securities pledged to an investor -  315,796  Loan receivable from a related party 351,486  269,539  Property, equipment and software, net 226,891  316,447  Intangible assets 116,475  116,500  Long-term investments 48,004  9,720  Operating lease right-of-use assets 118,845  144,029  Other non-current assets – third parties 78,408  67,009  Other non-current assets – related parties 569  1,113          Total non-current assets 1,041,659  1,242,725          Total assets 1,952,748  2,285,663          Lotus Technology Inc. Unaudited Condensed Consolidated Balance Sheets (Con’d) (All amounts in thousands)   As of    December 31, 2025  December 31, 2024    US$  US$  LIABILITIES AND SHAREHOLDERS' DEFICIT       Current liabilities       Short term borrowings – third parties 479,419  602,949  Short-term borrowings – related parties 784,288  199,570  Accounts payable – third parties 55,032  61,752  Accounts payable – related parties 458,189  410,433  Contract liabilities – third parties 18,459  33,964  Operating lease liabilities – third parties 11,598  14,094  Accrued expenses and other current liabilities – third parties 251,361  389,791  Accrued expenses and other current liabilities – related parties 213,529  214,760  Share buyback forward liabilities -  117,059  Put option liabilities -  309,115  Convertible notes - related parties 126,203  113,910          Total current liabilities 2,398,078  2,467,397          Non‑current liabilities       Contract liabilities – third parties 7,458  8,683  Operating lease liabilities – third parties 57,576  68,331  Operating lease liabilities – related parties 3,105  10,729  Warrant liabilities 800  3,340  Exchangeable notes 128,852  102,999  Convertible notes - third parties 73,226  74,246  Convertible notes - related parties 77,175  -  Long‑term borrowings 98,254  -  Deferred income 311,912  293,923  Deferred tax liabilities 698  -  Other non-current liabilities – third parties 125,004  114,770  Other non-current liabilities – related parties 856  1,471          Total non‑current liabilities 884,916  678,492          Total liabilities 3,282,994  3,145,889          Lotus Technology Inc. Unaudited Condensed Consolidated Balance Sheets (con’d) (All amounts in thousands)  As of  December 31, 2025 December 31, 2024  US$ US$ SHAREHOLDERS’ DEFICIT    Ordinary shares7  7  Treasury stock(138,397)  -  Additional paid-in capital1,933,992  1,785,664  Accumulated other comprehensive income39,818  55,165  Accumulated deficit(3,157,918)  (2,693,698)       Total shareholders' deficit attributable to ordinary shareholders(1,322,498)  (852,862)  Noncontrolling interests(7,748)  (7,364)  Total shareholders' deficit(1,330,246)  (860,226)       Total liabilities and shareholders' deficit1,952,748  2,285,663      Appendix B Lotus Technology Inc. Unaudited Condensed Consolidated Statements of Comprehensive loss (All amounts in thousands, except for share and per share data)   For the Year Ended December 31,   2025  2024    US$ US$ Revenues:     Sales of goods 462,802  891,061  Service revenues 56,296  33,288  Total revenues 519,098   924,349   Cost of revenues:     Cost of goods sold (430,031)  (867,061)  Cost of services (43,857)  (27,662)  Total cost of revenues (473,888)  (894,723)  Gross profit 45,210  29,626  Operating expenses:     Research and development expenses (170,960)  (274,801)  Selling and marketing expenses (148,261)  (322,310)  General and administrative expenses (135,850)  (227,475)  Other operating income 38,463  8,638  Impairment of long-lived assets (51,800)  -  Total operating expenses (468,408)  (815,948)  Operating loss (423,198)  (786,322)  Interest expenses (63,338)  (58,218)  Interest income 28,143  22,289  Investment income, net 10,740  14,232  Foreign currency exchange gains (losses), net 25,709  (11,664)  Changes in fair values of liabilities, excluding impact of instrument-specific credit risk (28,319)  (285,423)  Loss before income taxes and share of results of equity method investments (450,263)  (1,105,106)  Income tax expense (15,946)  (2,012)  Share of results of equity method investments 1,987  (171)  Net loss (464,222)  (1,107,289)  Less: Net loss attributable to noncontrolling interests (2)  (2,364)  Net loss attributable to ordinary shareholders (464,220)  (1,104,925)  Accretion of redeemable convertible preferred shares -  (2,979)  Net loss available to ordinary shareholders (464,220)  (1,107,904)  Loss per ordinary share1     —Basic and diluted (0.72)  (1.72)  Weighted average number of ordinary shares outstanding used in computing net loss per ordinary share1     —Basic and diluted 648,535,169  645,227,356          1 Shares outstanding for all periods reflect the adjustment for recapitalization upon the consummation of merger transaction in February 2024. Lotus Technology Inc. Unaudited Condensed Consolidated Statements of Comprehensive loss (cont’d) (All amounts in thousands, except for share and per share data)   For the Year Ended December 31,   2025  2024    US$ US$ Net loss (464,222)  (1,107,289)        Other comprehensive (loss) income:     Fair value changes of liabilities due to instrument-specific credit risk, net of nil income taxes 13,875  13,547  Foreign currency translation adjustment, net of nil income taxes (29,222)  16,351        Total other comprehensive (loss) income (15,347)  29,898        Total comprehensive loss (479,569)  (1,077,391)  Less: Total comprehensive loss attributable to noncontrolling interests (2)  (2,364)  Total comprehensive loss attributable to ordinary shareholders (479,567)  (1,075,027)        Appendix C Lotus Technology Inc. Unaudited Condensed Consolidated Statements of Comprehensive loss (All amounts in thousands, except for share and per share data)  For the Three Months Ended December 31,  2025  2024   US$ US$ Revenues:    Sales of goods132,410  266,812  Service revenues30,930  4,714  Total revenues163,340  271,526  Cost of revenues:    Cost of goods sold(122,748)  (286,241)  Cost of services(24,124)  (14,774)  Total cost of revenues(146,872)  (301,015)  Gross profit (loss)16,468  (29,489)  Operating expenses:    Research and development expenses(41,154)  (47,276)  Selling and marketing expenses(31,597)  (62,506)  General and administrative expenses(43,183)  (52,133)  Other operating income33,512  2,827  Impairment of long-lived assets(154)  -  Total operating expenses(82,576)  (159,088)  Operating loss(66,108)  (188,577)  Interest expenses(22,299)  (37,661)  Interest income7,569  7,013  Investment (loss) income, net(305)  3,433  Foreign currency exchange losses, net(2,735)  (26,627)  Changes in fair values of liabilities, excluding impact of instrument-specific credit risk389  (197,361)  Loss before income taxes and share of results of equity method investments(83,489)  (439,780)  Income tax benefit (expense)739  (857)  Share of results of equity method investments(3,017)  (132)  Net loss(85,767)  (440,769)  Less: Net loss attributable to noncontrolling interests-  (962)  Net loss attributable to ordinary shareholders(85,767)  (439,807)  Loss per ordinary share    —Basic and diluted(0.14)  (0.66)  Weighted average number of ordinary shares outstanding used in computing net loss per ordinary share    —Basic and diluted628,115,136  670,513,486         Lotus Technology Inc. Unaudited Condensed Consolidated Statements of Comprehensive loss (con’d) (All amounts in thousands, except for share and per share data)   For the Three Months Ended December 31,   2025  2024    US$ US$ Net loss (85,767)  (440,769)        Other comprehensive (loss) income (i):     Fair value changes of liabilities due to instrument-specific credit risk, net of nil income taxes 9,881  13,317  Foreign currency translation adjustment, net of nil income taxes (10,126)  16,233        Total other comprehensive (loss) income (245)  29,550        Total comprehensive loss (86,012)  (411,219)  Less: Total comprehensive loss attributable to noncontrolling interests -  (962)  Total comprehensive loss attributable to ordinary shareholders (86,012)  (410,257)          (i) The Company identified a mathematical error in the total other comprehensive loss in the unaudited condensed consolidated statement of comprehensive loss for the three months ended September 30, 2025, included in the Company’s press release for the third quarter of 2025 on Form 6-K previously furnished to the SEC on November 24, 2025. The financial information for the nine months ended September 30, 2025 was correctly stated. The revised total other comprehensive loss for the three months ended September 30, 2025 was US$25.2 million, comprised of US$12.4 million of “fair value changes of liabilities due to instrument-specific credit risk, net of nil income taxes” and US$12.8 million of “foreign currency translation adjustment, net of nil income taxes”, respectively. The revised total comprehensive loss and total comprehensive loss attributable to ordinary shareholders for the three months ended September 30, 2025 was US$90.6 million. The Company concluded the error was not material to the Company’s financial position or results of operations for any prior periods. Appendix D Lotus Technology Inc. Unaudited Reconciliation of GAAP and Non-GAAP results (Adjusted net loss/Adjusted EBITDA) (All amounts in thousands)  For the Twelve Months Ended December 31,  2025  2024   US$ US$ Net loss(464,222)  (1,107,289)  Share-based compensation expenses2,274  31,930  Adjusted net loss(461,948)  (1,075,359)  Net loss(464,222)  (1,107,289)  Interest expenses63,338  58,218  Interest income(28,143)  (22,289)  Income tax expense15,946  2,012  Share-based compensation expenses2,274  31,930  Depreciation54,740  76,488  Adjusted EBITDA(356,067)  (960,930)          For the Three Months Ended December 31,  2025  2024   US$ US$ Net loss(85,767)  (440,769)  Share-based compensation expenses19  (1,635)  Adjusted net loss(85,748)  (442,404)  Net loss(85,767)  (440,769)  Interest expenses22,299  37,661  Interest income(7,569)  (7,013)  Income tax expense(739)  857  Share-based compensation expenses19  (1,635)  Depreciation9,730  13,335  Adjusted EBITDA(62,027)  (397,564)

Johannesburg, South Africa, April 10th, 2026, Chainwire

Click here to register SAN FRANCISCO, CA / ACCESS Newswire / April 9, 2026 / Jaguar Health, Inc.(NASDAQ:JAGX) Participation Instructions for Webcast When: Friday, April 10, 2026 at 8:30 a.m. Eastern Participant Registration & Access Link: Click Here Replay Instructions for Webcast Replay of the webcast on the investor relations section of Jaguar's website: (click here) About the Jaguar Health Family of Companies Jaguar Health, Inc. ("Jaguar") develops novel proprietary prescription drugs sustainably derived from plants for people with complicated gastrointestinal ("GI") disease states. Jaguar family companies Napo Pharmaceuticals, Inc. and Napo Therapeutics S.p.A. focus on the development and commercialization of novel crofelemer powder for oral solution for the treatment of rare and orphan gastrointestinal disorders with intestinal failure, including microvillus inclusion disease and short bowel syndrome. Magdalena Biosciences, a joint venture formed by Jaguar and Filament Health Corp. that emerged from Jaguar's Entheogen Therapeutics Initiative (ETI), is focused on developing novel prescription medicines derived from plants for mental health indications. For more information about: Jaguar Health, visit https://jaguar.health Napo Therapeutics, visit napotherapeutics.com Magdalena Biosciences, visit magdalenabiosciences.com Forward-Looking Statements Certain statements in this press release constitute "forward-looking statements." These include statements regarding Jaguar's expectation that it will hold an investor webcast on April 1, 2026. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expect," "plan," "aim," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "estimate," "predict," "potential" or "continue" or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to several risks, uncertainties, and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar's control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. Contact: hello@jaguar.health Jaguar-JAGX SOURCE: Jaguar Health, Inc. View the original press release on ACCESS Newswire

MIAMI, FL / ACCESS Newswire / April 9, 2026 / Digi Power X Inc. (Nasdaq:DGXX)(CboeCanada:DGX) (the "Company"), an innovative energy infrastructure company pivoting into AI data centers and GPU-as-a-Service, announces that it has entered into an amended and restated sales agreement (the "ATM Agreement") with A.G.P./Alliance Global Partners (the "Agent"). As described in the Company's press releases dated May 30, 2025 and November 18, 2025, the Company previously entered into a sales agreement dated May 30, 2025 with the Agent, pursuant to which the Company established an "at-the-market" equity offering program (the "ATM Equity Program"). Pursuant to the ATM Equity Program, the Company may, at its discretion and from time-to-time during the term of the ATM Agreement, sell, through or to the Agent, such number of subordinate voting shares of the Company ("SV Shares") having an aggregate offering price of up to US$75 million. Sales of SV Shares, if any, in the ATM Equity Program are anticipated to be made in transactions that are deemed to be "at the market offerings" as defined in Rule 415(a)(4) under the U.S. Securities Act of 1933, as amended, directly on the Nasdaq Capital Market or another trading market for the SV Shares in the United States at the market price prevailing at the time of each sale. No SV Shares will be offered or sold under the ATM Equity Program in Canada, to anyone known by the Agent to be a resident of Canada or over or through the facilities of Cboe Canada or any other exchange or market in Canada. The ATM Equity Program may be terminated by either party at any time. The Company intends to use the net proceeds of the ATM Equity Program, if any, primarily for general corporate purposes, including funding ongoing operations and/or working capital requirements, completing construction on the Company's Tier 3 data center facilities, repaying indebtedness outstanding from time to time, and completing potential acquisitions to expand power infrastructure capacity and build out its planned AI and HPC network. Since the SV Shares will be distributed at trading prices prevailing at the time of the sale, prices may vary between purchasers during the period of distribution. The volume and timing of sales, if any, will be determined at the sole discretion of the Company's management and in accordance with the terms of the ATM Agreement. Offers and sales of the SV Shares in the ATM Equity Program, if any, will be made pursuant to a prospectus supplement and accompanying prospectus, in each case, filed with the Company's U.S. shelf registration statement on Form S-3 initially filed with the United States Securities and Exchange Commission (the "SEC") on April 9, 2026. The registration statement, including the prospectus supplement and the accompanying prospectus, in each case, filed with the registration statement is available on the SEC's EDGAR website at www.sec.gov/EDGAR. This news release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States or in any jurisdiction where the offer, sale or solicitation would be unlawful. The SV Shares referred to in this news release may not be offered or sold in the United States absent registration (including until the Company's registration statement on Form S-3 is declared effective by the SEC) or an applicable exemption from registration. About Digi Power X Digi Power X is an innovative energy infrastructure company developing AI data centers to drive the expansion of sustainable energy assets. Headquartered in Miami, Florida, the Company is executing a strategic transformation into AI infrastructure, GPU-as-a-Service, and modular data center deployment. With 400 megawatts of AI capacity targeted across Alabama, Upstate New York, and North Carolina, Digi Power X is positioning itself to become a leading independent AI infrastructure provider in North America. For more information, visit www.digipowerx.com. Investor Relations For further information, please contact: Michel Amar, Chief Executive Officer Digi Power X Inc. www.digipowerx.com Investor Relations: T: 888-474-9222 | Email: IR@digihostpower.com Cautionary Statement Trading in the securities of the Company should be considered highly speculative. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. Cboe Canada does not accept responsibility for the adequacy or accuracy of this release. Forward-Looking Statements Except for the statements of historical fact, this news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking information") that are based on expectations, estimates and projections as at the date of this news release and are covered by safe harbors under Canadian and United States securities laws. Forward-looking information in this news release includes statements regarding the business of the Company. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expects," "plans," "anticipates," "could," "intends," "targets," "goals,' "projects," "contemplates," "believes," "estimates," "forecasts," "predicts," "potential" or "continue" or the negative of these terms or other similar expressions. The forward-looking information is subject to a variety of known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to: future capital needs and uncertainty regarding the Company's ability to raise additional capital; costs associated with the development, manufacturing and deployment of AI infrastructure; global demand for AI computing infrastructure; further improvements to profitability and efficiency may not be realized; and other related risks, some of which are more fully set out in the Company's annual report on Form 10-K for the year ended December 31, 2025 and other documents disclosed in the Company's filings at www.sedarplus.ca and in the Company's annual, quarterly and current reports filed with the SEC on its website, www.SEC.gov/EDGAR. The forward-looking information in this news release reflects the current expectations, assumptions and/or beliefs of the Company based on information currently available to the Company. Although the Company believes that the assumptions inherent in the forward-looking information are reasonable, forward-looking information is not a guarantee of future performance and accordingly undue reliance should not be put on such information due to the inherent uncertainties therein. The Company undertakes no obligation to revise or update any forward-looking information other than as required by applicable law. SOURCE: Digi Power X Inc. View the original press release on ACCESS Newswire

Top stocks to trade this afternoon. $ONCO, $KBLB, $ARAI, $EOSE, $ZNTL

Datavault AI (NASDAQ: DVLT) announced it signed $750 million in aggregate tokenization contracts during the first quarter of 2026, generating approximately $77 million in associated fees across banking, IP licensing, minting and related services, supporting its previously stated full-year revenue guidance of at least $200 million. The contracts span multiple asset categories, including copper and gold […]